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Abstract Photodynamic therapy (PDT) is a clinical approach
that utilizes light-activated drugs for the treatment of a variety of
pathologic conditions. The initiating events of PDT-induced
apoptosis are poorly defined. It has been shown for other pro-
apoptotic stimuli that the integral endoplasmic reticulum protein
Bap31 is cleaved by caspases 1 and 8, but not by caspase-3.
Further, a 20 kDa Bap31 cleavage fragment is generated which
can induce apoptosis. In the current report, we sought to
determine whether Bap31 cleavage and generation of p20 is an
early event in PDT-induced apoptosis. The mitochondrial release
of cytochrome c, involvement of caspases 1, 2, 3, 4, 6, 7, 8, and 10
and the status of several known caspase substrates, including
Bap31, were evaluated in PDT-treated HeLa cells. Cytochrome
c appeared in the cytosol immediately following light activation
of the photosensitizer benzoporphyrin derivative monoacid ring
A. Activation of caspases 3, 6, 7, and 8 was evident within 1^2 h
post PDT. Processing of caspases 1, 2, 4, and 10 was not
observed. Cleavage of Bap31 was observed at 2^3 h post PDT.
The caspase-3 inhibitor DEVD-fmk blocked caspase-8 and
Bap31 cleavage suggesting that caspase-8 and Bap31 processing
occur downstream of caspase-3 activation in PDT-induced
apoptosis. These results demonstrate that release of mitochon-
drial cytochrome c into the cytoplasm is a primary event
following PDT, preceding caspase activation and cleavage of
Bap31. To our knowledge, this is the first example of a
chemotherapeutic agent inducing caspase-8 activation and
demonstrates that caspase-8 activation can occur after cyto-
chrome c release.
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1. Introduction
It is becoming increasingly evident that the same genetic
defects that promote the growth and survival of tumor cells
may also contribute to their resistance against various anti-
cancer agents [1,2]. Thus, intense research has been devoted to
understanding the molecular processes involved in apoptotic
cell death and devising therapeutic strategies that can selec-
tively restore the apoptotic potential to tumor cells.
Disruption of mitochondrial function is a critical event in
the apoptotic process leading to the elimination of cells
treated with chemotherapeutic agents [2]. Opening of the mi-
tochondrial megachannel (also called permeability transition
pore) has been implicated as a key event in the disruption of
mitochondrial membrane integrity during apoptosis [2]. Many
intrinsic factors can induce opening of the megachannel in-
cluding members of the Bcl-2/Bax family, cellular redox sta-
tus, cytosolic Ca2 levels, ceramide, and amphipathic peptides
[3]. Disruption of mitochondrial membrane integrity involves
the loss of metabolic functions and release of proteins from
the mitochondrial intermembrane space into the cytosol. Cy-
tochrome c and AIF (apoptosis inducing factor) represent two
such proteins, which when released into the cytosol, promote
caspase and/or nuclease activation [4^7].
Proteolytic cleavage of certain cellular substrates by casp-
ases plays a central role in the apoptotic process. Caspases
(cysteinyl aspartate-speci¢c proteinases), present in the cyto-
plasm as zymogens, require processing by other proteases,
often another caspase, or by autocatalytic cleavage to produce
the active form [1]. Caspase precursors are cleaved at inter-
nally conserved sequences of amino acids residues with Asp
residing in the P1 cleavage site [8]. Phylogenetic analysis has
revealed that caspases may be grouped into two major sub-
families : the ICE and CED-3 subfamilies [9]. Members of the
ICE subfamily (caspases 1, 4, 5, 11 and 13) may have subsid-
iary roles in pro-in£ammatory events such as cytokine mobil-
ization, whereas members of the CED-3 subfamily (caspases
2, 3, 6, 7, 8, 9, and 10) are primarily involved in apoptosis [9].
Caspase-3, considered one of the central executioner mole-
cules, is responsible for cleaving various proteins thereby dis-
abling important cellular structural, functional and repair
processes [9^11]. Three mitochondria-related apoptotic pro-
tease activating factors (Apafs) may play a key role in the
activation of caspase-3 [12]. Apaf-1 contains a conserved ami-
no acid sequence in its prodomain termed the caspase recruit-
ment domain (CARD) that binds caspases containing similar
CARDs at their NH2 terminus [12,13]. In the presence of
cytochrome c (Apaf-2) and dATP, Apaf-1 binds to and facil-
itates caspase-9 (Apaf-3) processing which then cleaves cas-
pase-3 [4].
Although the mitochondrial events pertaining to the onset
of apoptosis have been well characterized, limited research has
been done concerning the possible role of the endoplasmic
reticulum (ER) in this process. A role for Bcl-2 in ER function
has been proposed recently [14]. Bap31, a 28 kDa integral ER
protein, was originally described as a co-precipitant with
membrane-bound immunoglobulin D in B cell lysates [15].
Bap31 may act as a shuttle protein between the ER and the
intermediate compartment and/or cis-Golgi complex [16].
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Bap31 also has been shown to bind to caspases 1 and 8, but
not caspase-3 and forms complexes with Bcl-2 or Bcl-XL [14].
During apoptosis, Bap31 is cleaved, generating a 20 kDa
product which itself can induce apoptosis when expressed ec-
topically in otherwise normal cells [14].
Photodynamic therapy (PDT) involves the topical or sys-
temic application of a photosensitizing agent followed by il-
lumination with a speci¢c wavelength of light which catalyzes
the production of reactive oxygen species to produce the cy-
totoxic e¡ect [17]. PDT, using benzoporphyrin derivative
monoacid ring A (BPD-MA, vertepor¢n) as the photosensi-
tizer, induces apoptosis in several cell types [18^20]. It has also
been demonstrated that overexpression of Bcl-2 or Bcl-XL
prevents caspase-3 activation, cleavage of speci¢c cellular pro-
teins, and DNA fragmentation implicating caspase-3 as a key
player in PDT-induced apoptosis [18,21,22].
In the present report, we show that cytochrome c release
occurs immediately following light activation of BPD-MA
while caspase activation and Bap31 cleavage occur at a sig-
ni¢cantly later time. In particular, caspase-8 activation oc-
curred after mitochondrial cytochrome c release and activa-
tion was inhibited by the general caspase inhibitor ZVAD-
fmk, as well as by the caspase-3/7 inhibitor DEVD-fmk, in-
dicating that caspase-8 may be activated at a later stage dur-
ing PDT-induced apoptosis.
2. Materials and methods
2.1. Reagents
Liposomally formulated BPD-MA was provided by QLT Photo-
Therapeutics Inc. (Vancouver, BC). Antibodies were obtained from
the following sources: rabbit anti-caspases 1, 3 and 6 and mouse anti-
caspase-8 (Upstate Biotechnology Inc., Lake Placid, NY), mouse anti-
caspases 2 and 7 and Ras GTPase-activating protein (Ras-GAP)
(Transduction Laboratories, Mississauga, Ont.), rabbit anti-caspase-
4 (Oncogene Research Products, Cambridge, MA), mouse anti-cyto-
chrome c and caspase-9 (Pharmingen, Mississauga, Ont.), goat anti-
caspase-10 (Research Diagnostics Inc., Flanders, NJ), rabbit anti-
DNA fragmentation factor (DFF) (Dr. Xiaodong Wang, University
of Texas Southwestern Medical School, Dallas, TX), mouse anti-
poly(ADP-ribose) polymerase (PARP) (Biomol Research Laborato-
ries, Plymouth Meeting, PA), rabbit anti-Bap31. All other drugs
and chemicals, unless speci¢ed, were from Sigma Chemical Co. (St.
Louis, MO).
2.2. Cell culture
HeLa cells (ATCC, Rockford, MD) were maintained in DMEM
medium supplemented with 10% heat-inactivated fetal bovine serum
(FBS), 4 mM L-glutamine, 1 mM sodium pyruvate, 1 mM HEPES,
penicillin (100 U/ml) and streptomycin (100 Wg/ml) (Gibco BRL, Bur-
lington, Ont.).
2.3. Photoactivation of BPD-MA
For photodynamic studies, HeLa cells were incubated for a total of
60 min at 37‡C with or without BPD-MA (0 or 200 ng/ml) in DMEM
supplemented with 2% FBS. For caspase inhibition studies, Z-Asp-
Glu-Val-Asp-£uoromethylketone (Z-DEVD-fmk) (50 WM) (Enzyme
Systems Products, Dublin, CA) or Z-Val-Ala-Asp-£uoromethylketone
(ZVAD-fmk) (50, 100 or 200 WM) (Bachem, Torrance, CA) was added
to cells for the ¢nal 30 min of the BPD-MA incubation period prior
to light activation. Following drug incubation, cells were exposed to
£uorescent red light (620^700 nm) delivered at a rate of 5.6 mW/cm2
to give a total dose of 2 J/cm2. Cells were maintained in petri dishes at
37‡C until further analysis.
2.4. Preparation of whole protein extracts
To obtain whole cell lysates, cells were washed twice in PBS and
lysed in 1 ml of lysis bu¡er (1% Nonidet P-40 (NP-40), 20 mM Tris,
pH 8, 137 mM NaCl, 10% glycerol) supplemented with 1 mM phenyl-
methylsulfonyl £uoride, aprotinin (0.15 U/ml), and 1 mM sodium
orthovanadate for 20 min on ice as described [18].
2.5. Preparation of cytosolic protein extracts
To evaluate mitochondrial cytochrome c release, cytosolic protein
extracts (S-100) were obtained as previously described [23]. Brie£y,
cells were washed twice with PBS and cell pellets were resuspended
in 700 Wl ice-cold bu¡er containing 20 mM HEPES pH 7.5, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and
1 mM PMSF. Cells were disrupted using a Kontes dounce
homogenizer. Lysate was centrifuged at 10 000Ug for 10 min and
the resultant supernatant was further centrifuged at 100 000Ug for
1 h in a Beckman Optima TLX ultracentrifuge (Beckman, Palo
Alto, CA) using a TL-100 rotor.
2.6. Protease assay
A cell-free protease assay was performed by incubating 50 Wg of cell
lysate protein in 150 Wl of reaction bu¡er (1% NP-40, 20 mM Tris, pH
7.5, 137 mM NaCl, 10% glycerol) containing 100 WM of caspase-3
(acetyl-Asp-Glu-Val-Asp-amino-4-methylcoumarin (Ac-DEVD-
AMC)) (Calbiochem, Cambridge, MA) or caspase-8 (Z-Ile-Glu-Thr-
Asp-7-amino-4-tri£uoromethylcoumarin (Z-IETD-AFC)) substrate in
96-well microtiter plates [18]. Lysates were incubated at 37‡C for 4 h
and cleaved substrate £uorescence levels were determined using a
CytoFluor 2350 (PerSeptive Biosystems, Ont.) set at excitation and
emission wavelengths of 360 nm and 460 nm for caspase-3 and 360
nm and 490 nm for caspase-8.
2.7. Immunoblot analysis
Detergent soluble proteins (30 Wg) were separated by SDS-PAGE in
10% acrylamide gels, under reducing conditions followed by Western
blotting [18]. Membranes were incubated with primary antibody for
45 min at room temperature. Membranes were probed with horse-
radish peroxidase-labelled anti-goat IgG, anti-mouse IgG or anti-rab-
bit IgG antibodies (1:5000) in PBS, 0.05% Tween 20, 5% (w/v) skim
milk powder for 30 min at room temperature. Proteins were detected
using the enhanced chemiluminescence detection system (Amersham,
Arlington Heights, IL) and bands visualized by autoradiography.
3. Results and discussion
3.1. PDT induces rapid apoptosis which is inhibited by
ZVAD-fmk
HeLa cells were examined by di¡erential interference con-
trast (DIC) microscopy to assess their morphology following
PDT. Cell shrinkage and membrane blebbing, characteristic
of apoptotic cells, were observed for some cells within 1 h
following light irradiation of cells treated with BPD-MA
(Fig. 1). These changes were clearly evident for the majority
of cells by 2 h post PDT. DEVD-ase activity, indicative of
caspase-3 and 7-like cleavage activity, paralleled the DIC mi-
croscopy observations (Fig. 1B). DEVD-ase activity was de-
tected in cell lysates by 1 h post PDT. PDT-treated cells were
also annexin-V-positive after 2 h (data not shown), providing
further evidence of apoptosis. Treatment of cells with BPD-
MA in the absence of light had no e¡ect on caspase activity or
cell viability. We have previously demonstrated that pretreat-
ment with caspase inhibitors or overexpression of Bcl-2 or
Bcl-XL blocked PDT-induced caspase-3 activation and DNA
fragmentation in HL-60 cells [18,21,22]. To con¢rm that cas-
pases were involved in PDT-induced cell killing of HeLa cells,
cells were pretreated with increasing concentrations of the
general caspase inhibitor ZVAD-fmk prior to PDT. With in-
creasing concentrations of ZVAD-fmk, morphologic apop-
totic changes such as membrane blebbing and cell shrinkage
became less evident for PDT-treated cells (Fig. 2). These re-
sults show that caspases are intimately involved in the forma-
tion of the apoptotic phenotype observed for HeLa cells fol-
lowing PDT.
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Fig. 1. PDT induces changes in HeLa cell morphology associated with apoptosis and increased caspase-3-like (DEVD-ase) activity. Cells were
incubated without BPD-MA (untreated), with BPD-MA in the absence of light (BPD-MA), or with BPD-MA followed by light irradiation
(PDT). A: Cells were examined 0, 1, 2, 3, 4, and 5 h post PDT. B: Cells were lysed 0, 1, 2, 3, 4 and 5 h post PDT and cell extracts were ana-
lyzed for DEVD-ase cleavage activity by a cell-free protease assay.
Fig. 2. Caspases are involved in PDT-induced HeLa cell morphological changes. Prior to light activation of BPD-MA, cells were incubated
with di¡erent concentrations of the general caspase family inhibitor ZVAD-fmk. Following PDT, cells were maintained for a further 2 h and
their phenotype was assessed by DIC microscopy.
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3.2. PDT induces caspases 3, 6, 7 and 8 cleavage in HeLa cells
Our next step was to assess the status of several members of
the caspase family during PDT-induced apoptosis of HeLa
cells. Caspases 3, 6, 7, and 8, but not caspases 1, 2, 4 and
10, were processed following PDT (Fig. 3). Caspase-9 was not
detectable with the antibody utilized. Interestingly, caspase-8
processing was not evident prior to cleavage of caspases 3, 6
and 7. The involvement of caspase-8 as an early upstream
e¡ector caspase in receptor-mediated apoptosis instigated by
FasL and tumor necrosis factor (TNF) has been well docu-
mented [24^26]. However, with the exception of UV irradia-
tion, which may initiate the Fas pathway [27], we were unable
to identify a chemotherapeutic agent that invokes caspase-8
activation.
In co-transfected human cells, pro-caspase-8 has been
shown to interact with Ced-4, an adaptor molecule found in
Caenorhabditis elegans that binds to and activates the caspase-
3 homologue Ced-3 [28]. Furthermore, the predicted death
e¡ector homology domain within the cytosolic region of
Bap31 interacts with Ced-4 and contributes to recruitment
of pro-caspase-8 [29]. It is conceivable that Apaf-1, the human
homologue of Ced-4, may bind to and activate caspase-8
upon recruitment to a Bap31/Apaf-1 complex during apopto-
sis. This hypothesis will be tested in future studies. To further
discern the role for caspases in PDT-induced apoptosis, we
examined cleavage of the known caspase substrates PARP,
DFF and Ras-GAP [30^32]. As expected, these substrates
were all cleaved following PDT (Fig. 4).
3.3. Cytochrome c is released immediately following PDT and
prior to caspase-8 processing
Since it has been well documented that caspase-8 is the ¢rst
caspase activated in Fas-, TRAIL- and TNF-induced apopto-
sis [26,33,34], we sought to determine whether caspase-8 acti-
vation occurs prior to, as in Fas- and TNF-induced apoptosis,
or after cytochrome c release. Whole cell extracts and cyto-
solic (S-100) protein extracts were analyzed for cytochrome c
content by Western blotting (Fig. 5). Detection of cytochrome
c in the cytosolic S-100 fraction corresponds to the release of
cytochrome c from the mitochondria [4]. Cytochrome c was
readily detectable within the cytosolic fraction prepared im-
mediately following light activation indicating that cyto-
chrome c release is an early event in PDT-induced apoptosis.
Cytochrome c was undetectable in the S-100 cytosolic frac-
tions of untreated cells or cells treated with BPD-MA in the
absence of light. The rapid appearance of cytochrome c in the
cytosol following PDT may be attributed to the direct action
and localization of photosensitizers to mitochondria [17].
Caspase-8 activation was assessed by Western blotting and
by a cell-free protease assay that measures the cleavage activ-
ity of the caspase-8-speci¢c £uorogenically labeled IETD tet-
rapeptide (Fig. 5) [35]. Bap31 cleavage was evaluated in par-
allel over the 5 h period following light activation. Caspase-8
cleavage and activation, as well as Bap31 cleavage, occurred
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Fig. 5. Cytochrome c is detectable within the cytosol immediately
after light irradiation. HeLa cells were lysed at the indicated times
following PDT. Cell lysates were analyzed for caspase-8-like (IETD-
ase) cleavage activity using a cell-free protease assay. Whole cell ly-
sates were separated by SDS-PAGE followed by Western immuno-
blotting and probed for cytochrome c, caspase-8 or Bap31. S-100
cytosolic extracts were prepared to evaluate the presence of cyto-
chrome c in the cytosol.
Fig. 4. PDT induces caspase-mediated cleavage of DFF, PARP and
Ras-GAP. HeLa cells were lysed at the indicated times following
PDT. Cell lysates were separated by SDS-PAGE followed by West-
ern immunoblotting.
Fig. 3. Processing of caspases 3, 6, 7 and 8 but not caspases 1, 2, 4,
and 10 occurs in PDT-treated HeLa cells. Cell lysates were prepared
at the indicated times following PDT. These lysates were separated
by SDS-PAGE in 10% acrylamide gels followed by Western immu-
noblotting.
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at least 1^2 h after the appearance of cytochrome c in the
cytosol indicating that caspase-8 activation is not an initiating
event in PDT-induced apoptosis. Since caspase-1 is not acti-
vated and caspase-8 is the only other caspase known to bind
to and cleave Bap31 [14], Bap31 cleavage during PDT-induced
apoptosis provides further support of the existence of caspase-
8 activity in these cells.
3.4. ZVAD-fmk and DEVD-fmk inhibit PDT-induced
caspase-8 processing
Prolonged exposure of the Western blots during autora-
diography allowed the detection of both pro-caspase-8/a (55
kDa) and caspase-8/b (54 kDa) processing and the appearance
of 41 and 43 kDa caspase-8 intermediate cleavage products,
respectively [24] in PDT-treated cell lysates (Fig. 6). Cells were
pretreated with the general caspase family inhibitor ZVAD-
fmk or the caspase-3/7-speci¢c inhibitor DEVD-fmk prior to
light activation of BPD-MA. ZVAD-fmk and DEVD-fmk in-
hibited pro-caspase-8/a (55 kDa) and caspase-8/b (54 kDa)
processing and the appearance of 43 and 41 kDa caspase-8
intermediate cleavage products, respectively [24]. Both
ZVAD-fmk and DEVD-fmk inhibitors blocked the appear-
ance of Bap31 as well as PARP and DFF cleavage fragments
in PDT-treated cell lysates (Fig. 6).
In summary, mitochondrial cytochrome c release represents
an extremely early following PDT. Caspases 3, 6 and 7 were
activated in PDT-treated HeLa cells similar to events trig-
gered by other chemotherapeutic agents [36^38]. Caspase-8
activation followed cytochrome c release in PDT-treated cells.
Although the HeLa cells used in these experiments are Fas-
positive (unpublished results) and caspase-8 was activated,
due to the rapid release of mitochondrial cytochrome c into
the cytoplasm we do not believe that the dominant mechanism
of apoptotic cell death instigated by PDT occurs via the Fas
pathway. It is possible that triggering of the Fas/caspase-8
pathway represents a secondary means of ensuring the elimi-
nation of damaged cells. A detailed analysis of the role of the
Fas receptor system in PDT-induced apoptosis will be exam-
ined in future studies.
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